Clinical trial
Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in…
NCT00323947 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00323947 |
|---|---|
| Title | Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy |
| Official title | Double Blind, Placebo Controlled, Crossover Study of Extended Release Methylphenidate for Treatment of ADHD in Children With Epilepsy |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity, Epilepsy |
| Intervention type | Drug |
| Interventions | Extended Release Methylphenidate (OROS-Methylphenidate) |
| Enrollment | 33 |
| Start date | May 1, 2003 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 10, 2006 |
| Last update posted | Aug 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: